World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
11781
World Ranking
9874
National Ranking
4325

Bysani Chandrasekar publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Bysani Chandrasekar sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 175 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Bysani Chandrasekar D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Bysani Chandrasekar sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 64 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Bysani Chandrasekar is affiliated with the University of Missouri in the United States. Their research primarily focuses on the intersection of medicine and biochemistry, genetics, and molecular biology, with a significant emphasis on cardiology and cardiovascular medicine. They have contributed extensively to understanding cardiovascular function, disease, and molecular signaling pathways involved in these conditions.

Their work includes studies on cardiovascular disease and adiposity, NF-κB signaling pathways, cardiovascular function and risk factors, liver disease diagnosis and treatment, protease and inhibitor mechanisms, peptidase inhibition and analysis, and adipokines, inflammation, and metabolic diseases.

Among their recent publications are:

  • The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion (2020, Cellular Signalling)
  • Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death (2020, Cellular Signalling)
  • Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness (2021, Cardiovascular Diabetology)
  • Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling (2021, Cellular Signalling)
  • TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates Obesity-Associated Vascular Insulin Resistance and Dysfunction in Male Mice (2020, Hypertension)

They frequently publish in venues such as The FASEB Journal, Physiology, Cellular Signalling, Cells, and Circulation. Their work has been cited in various contexts related to cardiovascular and molecular biology research.

They collaborate frequently with a core group of researchers, including Shawn B. Bender, Luis A. Martinez-Lemus, Yusuke Higashi, Tadashi Yoshida, and Jacob J. Russell, indicating an active involvement in collaborative research efforts spanning multiple aspects of cardiovascular and cellular signaling studies.

Best Publications

  • The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response

    Peter C. Melby;Bysani Chandrasekar;Weigou Zhao;John E. Coe

  • beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.

    Sumanth D. Prabhu;Bysani Chandrasekar;David R. Murray;Gregory L. Freeman

  • Chronic β-Adrenergic Stimulation Induces Myocardial Proinflammatory Cytokine Expression

    David R. Murray;Sumanth D. Prabhu;Bysani Chandrasekar

  • Ischemia-Reperfusion of Rat Myocardium Activates Nuclear Factor-κB and Induces Neutrophil Infiltration Via Lipopolysaccharide-Induced CXC Chemokine

    Bysani Chandrasekar;Jeffrey B. Smith;Gregory L. Freeman

  • IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activation

    Dolores M. Cortez;Marc D. Feldman;Srinivas Mummidi;Anthony J. Valente

  • Interleukin-18-induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-κB- and AP-1-mediated Matrix Metalloproteinase-9 Expression and Is Inhibited by Atorvastatin

    Bysani Chandrasekar;Bysani Chandrasekar;Srinivas Mummidi;Srinivas Mummidi;Lenin Mahimainathan;Devang N. Patel

  • Decreased Proinflammatory Cytokines and Increased Antioxidant Enzyme Gene Expression by ω-3 Lipids in Murine Lupus Nephritis

    B. Chandrasekar;G. Fernandes

  • Interleukin-17 Stimulates C-reactive Protein Expression in Hepatocytes and Smooth Muscle Cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBPβ Activation

    Devang N. Patel;Carter A. King;Steven R. Bailey;Jeffrey W. Holt

  • Small Multifunctional Nanoclusters (Nanoroses) for Targeted Cellular Imaging and Therapy

    Li Leo Ma;Li Leo Ma;Marc David Feldman;Marc David Feldman;Jasmine M. Tam;Amit S. Paranjape

  • Malnutrition Alters the Innate Immune Response and Increases Early Visceralization following Leishmania donovani Infection

    Gregory M. Anstead;Bysani Chandrasekar;Weiguo Zhao;Jue Yang

  • CXCL16 Signals via Gi, Phosphatidylinositol 3-Kinase, Akt, IκB Kinase, and Nuclear Factor-κB and Induces Cell-Cell Adhesion and Aortic Smooth Muscle Cell Proliferation

    Bysani Chandrasekar;Sailaja Bysani;Srinivas Mummidi

  • Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.

    Bysani Chandrasekar;Srinivas Mummidi;Rao P Perla;Sailaja Bysani

  • Effects of n−3 and n−6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune‐prone NZB×NZW F1 mice

    Jaya T. Venkatraman;Bysani Chandrasekar;Jong Dai Kim;Gabriel Fernandes

  • Gender Is a Major Determinant of the Clinical Evolution and Immune Response in Hamsters Infected with Leishmania spp.

    Bruno L. Travi;Yaneth Osorio;Peter C. Melby;Peter C. Melby;Bysani Chandrasekar

  • Cloning of Syrian Hamster (Mesocricetus auratus) Cytokine cDNAs and Analysis of Cytokine mRNA Expression in Experimental Visceral Leishmaniasis

    Peter C. Melby;Victor V. Tryon;Bysani Chandrasekar;Gregory L. Freeman

  • Adiponectin Blocks Interleukin-18-mediated Endothelial Cell Death via APPL1-dependent AMP-activated Protein Kinase (AMPK) Activation and IKK/NF-κB/PTEN Suppression *

    Bysani Chandrasekar;William H. Boylston;Kaliyamurthi Venkatachalam;Nicholas J.G. Webster

  • Interleukin-18 Is a Pro-hypertrophic Cytokine That Acts through a Phosphatidylinositol 3-Kinase-Phosphoinositide-dependent Kinase-1-Akt-GATA4 Signaling Pathway in Cardiomyocytes

    Bysani Chandrasekar;Srinivas M. Mummidi;Srinivas M. Mummidi;William C. Claycomb;Ruben Mestril

  • Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion.

    Bysani Chandrasekar;Donald H. Mitchell;James T. Colston;Gregory L. Freeman

  • Activation of Intrinsic and Extrinsic Proapoptotic Signaling Pathways in Interleukin-18-mediated Human Cardiac Endothelial Cell Death

    Bysani Chandrasekar;Kirankumar Vemula;Rama Mohan Surabhi;Min Li-Weber

  • Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury

    Kaliyamurthi Venkatachalam;Sumanth D. Prabhu;Sumanth D. Prabhu;Venkatapuram Seenu Reddy;William H. Boylston

Frequent Co-Authors

Anthony J. Valente
Anthony J. Valente The University of Texas Health Science Center at San Antonio
Ulrich Siebenlist
Ulrich Siebenlist National Institutes of Health
Peter C. Melby
Peter C. Melby The University of Texas Medical Branch at Galveston
Makoto Noda
Makoto Noda Kyoto University
Keith P. Johnston
Keith P. Johnston The University of Texas at Austin
Sanjay K. Srivastava
Sanjay K. Srivastava Texas Tech University Health Sciences Center
Robert A. Clark
Robert A. Clark The University of Texas Health Science Center at San Antonio
Goutam Ghosh Choudhury
Goutam Ghosh Choudhury The University of Texas Health Science Center at San Antonio
Thomas E. Milner
Thomas E. Milner University of California, Irvine
Konstantin V Sokolov
Konstantin V Sokolov The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The fields of Biology and Biochemistry often overlap with many rewarding healthcare careers. For those considering further study, online degrees can provide flexibility and affordability, allowing you to specialize or switch career paths without relocating. For example, becoming a Family Nurse Practitioner can be more accessible through programs such as the cheapest post master's fnp program, designed for licensed nurses seeking advanced practice roles.

If your interests lie in nutrition or wellness, pursuing a dietitian degree online can open doors to clinical and educational opportunities. Registered nurses aiming to boost their credentials should explore the best online rn to bsn programs for efficient, career-enhancing education.

Leadership roles in healthcare are also achievable through graduate programs like the fastest online mha, which prepares students for management and administrative careers. Whether you’re starting out or looking to advance, these online pathways can help you reach your professional and academic goals in the life sciences.

Best Scientists Citing Bysani Chandrasekar

Trending Scientists

Recently Published Articles